Home » US FDA Provides ‘Closeout Letters’ to Warning Letter Recipients
US FDA Provides ‘Closeout Letters’ to Warning Letter Recipients
September 17, 2009
Drugmakers that have resolved issues in warning letters from the U.S. Food and Drug Administration (FDA) dated Sept. 1 or later — and have passed inspections that verify the corrective action — are eligible for closeout letters.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor